カテゴリー： 世界, 医療/バイオ, LP Information

世界のアンドロゲン受容体拮抗薬市場予測 2023年-2029年

【英語タイトル】Global Androgen Receptor Antagonist Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08451）・商品コード：LP23DC08451
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：96
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアンドロゲン受容体拮抗薬市場」は、過去の販売実績から2022年の世界のアンドロゲン受容体拮抗薬の総販売量を検討し、2023年から2029年の予測されるアンドロゲン受容体拮抗薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアンドロゲン受容体拮抗薬の市場規模を掲載し、XXX百万米ドル規模の世界のアンドロゲン受容体拮抗薬市場の詳細な分析を提供します。本インサイトレポートは、世界のアンドロゲン受容体拮抗薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアンドロゲン受容体拮抗薬市場における各社の独自のポジションをより深く理解するために、アンドロゲン受容体拮抗薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアンドロゲン受容体拮抗薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アンドロゲン受容体拮抗薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アンドロゲン受容体拮抗薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アンドロゲン受容体拮抗薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アンドロゲン受容体拮抗薬の世界主要メーカーとしては、Merck & Co., Inc、 Sanofi、 Astellas Pharma Inc、 Pfizer、 Johnson & Johnson、 Bayer、 Hinova、 Jiangsu Hengrui Pharmaceuticals Co., Ltd、 Kintor Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアンドロゲン受容体拮抗薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアンドロゲン受容体拮抗薬市場をセグメンテーションし、種類別 (第一世代インヒビター、第二世代インヒビター)、用途別 (前立腺がん、乳がん、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：第一世代インヒビター、第二世代インヒビター

・用途別区分：前立腺がん、乳がん、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアンドロゲン受容体拮抗薬市場の10年間の市場状況・展望は？
・世界および地域別に見たアンドロゲン受容体拮抗薬市場成長の要因は何か？
・アンドロゲン受容体拮抗薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・アンドロゲン受容体拮抗薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アンドロゲン受容体拮抗薬の年間販売量2018-2029、地域別現状・将来分析
・アンドロゲン受容体拮抗薬の種類別セグメント：第一世代インヒビター、第二世代インヒビター
・アンドロゲン受容体拮抗薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アンドロゲン受容体拮抗薬の用途別セグメント：前立腺がん、乳がん、その他
・アンドロゲン受容体拮抗薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアンドロゲン受容体拮抗薬市場
・企業別のグローバルアンドロゲン受容体拮抗薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアンドロゲン受容体拮抗薬の年間売上：2018-2023年の売上、市場シェア
・企業別のアンドロゲン受容体拮抗薬販売価格
・主要企業のアンドロゲン受容体拮抗薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アンドロゲン受容体拮抗薬の地域別レビュー
・地域別のアンドロゲン受容体拮抗薬市場規模2018-2023：年間販売量、売上
・主要国別のアンドロゲン受容体拮抗薬市場規模2018-2023：年間販売量、売上
・南北アメリカのアンドロゲン受容体拮抗薬販売の成長
・アジア太平洋のアンドロゲン受容体拮抗薬販売の成長
・ヨーロッパのアンドロゲン受容体拮抗薬販売の成長
・中東・アフリカのアンドロゲン受容体拮抗薬販売の成長

南北アメリカ市場
・南北アメリカの国別のアンドロゲン受容体拮抗薬販売量、売上（2018-2023）
・南北アメリカのアンドロゲン受容体拮抗薬の種類別販売量
・南北アメリカのアンドロゲン受容体拮抗薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアンドロゲン受容体拮抗薬販売量、売上（2018-2023）
・アジア太平洋のアンドロゲン受容体拮抗薬の種類別販売量
・アジア太平洋のアンドロゲン受容体拮抗薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアンドロゲン受容体拮抗薬販売量、売上（2018-2023）
・ヨーロッパのアンドロゲン受容体拮抗薬の種類別販売量
・ヨーロッパのアンドロゲン受容体拮抗薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアンドロゲン受容体拮抗薬販売量、売上（2018-2023）
・中東・アフリカのアンドロゲン受容体拮抗薬の種類別販売量
・中東・アフリカのアンドロゲン受容体拮抗薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アンドロゲン受容体拮抗薬の製造コスト構造分析
・アンドロゲン受容体拮抗薬の製造プロセス分析
・アンドロゲン受容体拮抗薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アンドロゲン受容体拮抗薬の主要なグローバル販売業者
・アンドロゲン受容体拮抗薬の主要なグローバル顧客

地域別のアンドロゲン受容体拮抗薬市場予測レビュー
・地域別のアンドロゲン受容体拮抗薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アンドロゲン受容体拮抗薬の種類別市場規模予測
・アンドロゲン受容体拮抗薬の用途別市場規模予測

主要企業分析
Merck & Co., Inc、 Sanofi、 Astellas Pharma Inc、 Pfizer、 Johnson & Johnson、 Bayer、 Hinova、 Jiangsu Hengrui Pharmaceuticals Co., Ltd、 Kintor Pharma
・企業情報
・アンドロゲン受容体拮抗薬製品
・アンドロゲン受容体拮抗薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Androgen Receptor Antagonist market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Androgen Receptor Antagonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Androgen Receptor Antagonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Androgen Receptor Antagonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Androgen Receptor Antagonist players cover Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer, Johnson & Johnson, Bayer, Hinova, Jiangsu Hengrui Pharmaceuticals Co., Ltd and Kintor Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Androgen receptor (AR) is an important target of prostate cancer drugs, and its structure plays an important guiding role in drug development. The androgen receptor consists of 4 structural domains and 8 exons, which are N-terminal binding domain (NTD, exon 1), DNA binding domain (DBD, exon 2-3), hinge region ( HR, exon 4), C-terminal binding domain (LBD, exons 5-8), nuclear localization signal (NLS) is a dichotomous motif contained within exons 3 and 4. The LBD contains a buried hormone-binding pocket (HBP) and a transcriptional activation domain, AF2. AF2 plays an important role in the formation of homodimers, AF2 contains helices 3, 4, 5 and 12 (H3, H4, H5, H12), H12 can change position when ligand binds, when ligand binds to the binding pocket Upon binding, H12 folds back closer to the binding site, preventing ligand disengagement. Non-steroidal AR antagonists avoid the common hormone-like toxic side effects of steroidal AR antagonists, expand clinical applications, and are currently the most commonly used prostate cancer drugs in the United States.
LPI (LP Information)’ newest research report, the “Androgen Receptor Antagonist Industry Forecast” looks at past sales and reviews total world Androgen Receptor Antagonist sales in 2022, providing a comprehensive analysis by region and market sector of projected Androgen Receptor Antagonist sales for 2023 through 2029. With Androgen Receptor Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androgen Receptor Antagonist industry.
This Insight Report provides a comprehensive analysis of the global Androgen Receptor Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androgen Receptor Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androgen Receptor Antagonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androgen Receptor Antagonist and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androgen Receptor Antagonist.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Receptor Antagonist market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
First Generation Inhibitors
Second Generation Inhibitors
Segmentation by application
Prostate Cancer
Breast Cancer
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck & Co., Inc
Sanofi
Astellas Pharma Inc
Pfizer
Johnson & Johnson
Bayer
Hinova
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Kintor Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Androgen Receptor Antagonist market?
What factors are driving Androgen Receptor Antagonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Androgen Receptor Antagonist market opportunities vary by end market size?
How does Androgen Receptor Antagonist break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Androgen Receptor Antagonist Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Androgen Receptor Antagonist by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Androgen Receptor Antagonist by Country/Region, 2018, 2022 & 2029
2.2 Androgen Receptor Antagonist Segment by Type
2.2.1 First Generation Inhibitors
2.2.2 Second Generation Inhibitors
2.3 Androgen Receptor Antagonist Sales by Type
2.3.1 Global Androgen Receptor Antagonist Sales Market Share by Type (2018-2023)
2.3.2 Global Androgen Receptor Antagonist Revenue and Market Share by Type (2018-2023)
2.3.3 Global Androgen Receptor Antagonist Sale Price by Type (2018-2023)
2.4 Androgen Receptor Antagonist Segment by Application
2.4.1 Prostate Cancer
2.4.2 Breast Cancer
2.4.3 Other
2.5 Androgen Receptor Antagonist Sales by Application
2.5.1 Global Androgen Receptor Antagonist Sale Market Share by Application (2018-2023)
2.5.2 Global Androgen Receptor Antagonist Revenue and Market Share by Application (2018-2023)
2.5.3 Global Androgen Receptor Antagonist Sale Price by Application (2018-2023)
3 Global Androgen Receptor Antagonist by Company
3.1 Global Androgen Receptor Antagonist Breakdown Data by Company
3.1.1 Global Androgen Receptor Antagonist Annual Sales by Company (2018-2023)
3.1.2 Global Androgen Receptor Antagonist Sales Market Share by Company (2018-2023)
3.2 Global Androgen Receptor Antagonist Annual Revenue by Company (2018-2023)
3.2.1 Global Androgen Receptor Antagonist Revenue by Company (2018-2023)
3.2.2 Global Androgen Receptor Antagonist Revenue Market Share by Company (2018-2023)
3.3 Global Androgen Receptor Antagonist Sale Price by Company
3.4 Key Manufacturers Androgen Receptor Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Androgen Receptor Antagonist Product Location Distribution
3.4.2 Players Androgen Receptor Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Androgen Receptor Antagonist by Geographic Region
4.1 World Historic Androgen Receptor Antagonist Market Size by Geographic Region (2018-2023)
4.1.1 Global Androgen Receptor Antagonist Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Androgen Receptor Antagonist Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Androgen Receptor Antagonist Market Size by Country/Region (2018-2023)
4.2.1 Global Androgen Receptor Antagonist Annual Sales by Country/Region (2018-2023)
4.2.2 Global Androgen Receptor Antagonist Annual Revenue by Country/Region (2018-2023)
4.3 Americas Androgen Receptor Antagonist Sales Growth
4.4 APAC Androgen Receptor Antagonist Sales Growth
4.5 Europe Androgen Receptor Antagonist Sales Growth
4.6 Middle East & Africa Androgen Receptor Antagonist Sales Growth
5 Americas
5.1 Americas Androgen Receptor Antagonist Sales by Country
5.1.1 Americas Androgen Receptor Antagonist Sales by Country (2018-2023)
5.1.2 Americas Androgen Receptor Antagonist Revenue by Country (2018-2023)
5.2 Americas Androgen Receptor Antagonist Sales by Type
5.3 Americas Androgen Receptor Antagonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Receptor Antagonist Sales by Region
6.1.1 APAC Androgen Receptor Antagonist Sales by Region (2018-2023)
6.1.2 APAC Androgen Receptor Antagonist Revenue by Region (2018-2023)
6.2 APAC Androgen Receptor Antagonist Sales by Type
6.3 APAC Androgen Receptor Antagonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Androgen Receptor Antagonist by Country
7.1.1 Europe Androgen Receptor Antagonist Sales by Country (2018-2023)
7.1.2 Europe Androgen Receptor Antagonist Revenue by Country (2018-2023)
7.2 Europe Androgen Receptor Antagonist Sales by Type
7.3 Europe Androgen Receptor Antagonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Androgen Receptor Antagonist by Country
8.1.1 Middle East & Africa Androgen Receptor Antagonist Sales by Country (2018-2023)
8.1.2 Middle East & Africa Androgen Receptor Antagonist Revenue by Country (2018-2023)
8.2 Middle East & Africa Androgen Receptor Antagonist Sales by Type
8.3 Middle East & Africa Androgen Receptor Antagonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Androgen Receptor Antagonist
10.3 Manufacturing Process Analysis of Androgen Receptor Antagonist
10.4 Industry Chain Structure of Androgen Receptor Antagonist
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Androgen Receptor Antagonist Distributors
11.3 Androgen Receptor Antagonist Customer
12 World Forecast Review for Androgen Receptor Antagonist by Geographic Region
12.1 Global Androgen Receptor Antagonist Market Size Forecast by Region
12.1.1 Global Androgen Receptor Antagonist Forecast by Region (2024-2029)
12.1.2 Global Androgen Receptor Antagonist Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Androgen Receptor Antagonist Forecast by Type
12.7 Global Androgen Receptor Antagonist Forecast by Application
13 Key Players Analysis
13.1 Merck & Co., Inc
13.1.1 Merck & Co., Inc Company Information
13.1.2 Merck & Co., Inc Androgen Receptor Antagonist Product Portfolios and Specifications
13.1.3 Merck & Co., Inc Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck & Co., Inc Main Business Overview
13.1.5 Merck & Co., Inc Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Androgen Receptor Antagonist Product Portfolios and Specifications
13.2.3 Sanofi Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Astellas Pharma Inc
13.3.1 Astellas Pharma Inc Company Information
13.3.2 Astellas Pharma Inc Androgen Receptor Antagonist Product Portfolios and Specifications
13.3.3 Astellas Pharma Inc Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Astellas Pharma Inc Main Business Overview
13.3.5 Astellas Pharma Inc Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Androgen Receptor Antagonist Product Portfolios and Specifications
13.4.3 Pfizer Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Androgen Receptor Antagonist Product Portfolios and Specifications
13.5.3 Johnson & Johnson Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Androgen Receptor Antagonist Product Portfolios and Specifications
13.6.3 Bayer Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Hinova
13.7.1 Hinova Company Information
13.7.2 Hinova Androgen Receptor Antagonist Product Portfolios and Specifications
13.7.3 Hinova Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hinova Main Business Overview
13.7.5 Hinova Latest Developments
13.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
13.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
13.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product Portfolios and Specifications
13.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Main Business Overview
13.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Latest Developments
13.9 Kintor Pharma
13.9.1 Kintor Pharma Company Information
13.9.2 Kintor Pharma Androgen Receptor Antagonist Product Portfolios and Specifications
13.9.3 Kintor Pharma Androgen Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kintor Pharma Main Business Overview
13.9.5 Kintor Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Androgen Receptor Antagonist Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Androgen Receptor Antagonist Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of First Generation Inhibitors
Table 4. Major Players of Second Generation Inhibitors
Table 5. Global Androgen Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 6. Global Androgen Receptor Antagonist Sales Market Share by Type (2018-2023)
Table 7. Global Androgen Receptor Antagonist Revenue by Type (2018-2023) & ($ million)
Table 8. Global Androgen Receptor Antagonist Revenue Market Share by Type (2018-2023)
Table 9. Global Androgen Receptor Antagonist Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Androgen Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 11. Global Androgen Receptor Antagonist Sales Market Share by Application (2018-2023)
Table 12. Global Androgen Receptor Antagonist Revenue by Application (2018-2023)
Table 13. Global Androgen Receptor Antagonist Revenue Market Share by Application (2018-2023)
Table 14. Global Androgen Receptor Antagonist Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Androgen Receptor Antagonist Sales by Company (2018-2023) & (K Units)
Table 16. Global Androgen Receptor Antagonist Sales Market Share by Company (2018-2023)
Table 17. Global Androgen Receptor Antagonist Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Androgen Receptor Antagonist Revenue Market Share by Company (2018-2023)
Table 19. Global Androgen Receptor Antagonist Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Androgen Receptor Antagonist Producing Area Distribution and Sales Area
Table 21. Players Androgen Receptor Antagonist Products Offered
Table 22. Androgen Receptor Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Androgen Receptor Antagonist Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Androgen Receptor Antagonist Sales Market Share Geographic Region (2018-2023)
Table 27. Global Androgen Receptor Antagonist Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Androgen Receptor Antagonist Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Androgen Receptor Antagonist Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Androgen Receptor Antagonist Sales Market Share by Country/Region (2018-2023)
Table 31. Global Androgen Receptor Antagonist Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Androgen Receptor Antagonist Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Androgen Receptor Antagonist Sales by Country (2018-2023) & (K Units)
Table 34. Americas Androgen Receptor Antagonist Sales Market Share by Country (2018-2023)
Table 35. Americas Androgen Receptor Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Androgen Receptor Antagonist Revenue Market Share by Country (2018-2023)
Table 37. Americas Androgen Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 38. Americas Androgen Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 39. APAC Androgen Receptor Antagonist Sales by Region (2018-2023) & (K Units)
Table 40. APAC Androgen Receptor Antagonist Sales Market Share by Region (2018-2023)
Table 41. APAC Androgen Receptor Antagonist Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Androgen Receptor Antagonist Revenue Market Share by Region (2018-2023)
Table 43. APAC Androgen Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 44. APAC Androgen Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 45. Europe Androgen Receptor Antagonist Sales by Country (2018-2023) & (K Units)
Table 46. Europe Androgen Receptor Antagonist Sales Market Share by Country (2018-2023)
Table 47. Europe Androgen Receptor Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Androgen Receptor Antagonist Revenue Market Share by Country (2018-2023)
Table 49. Europe Androgen Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 50. Europe Androgen Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Androgen Receptor Antagonist Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Androgen Receptor Antagonist Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Androgen Receptor Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Androgen Receptor Antagonist Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Androgen Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Androgen Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Androgen Receptor Antagonist
Table 58. Key Market Challenges & Risks of Androgen Receptor Antagonist
Table 59. Key Industry Trends of Androgen Receptor Antagonist
Table 60. Androgen Receptor Antagonist Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Androgen Receptor Antagonist Distributors List
Table 63. Androgen Receptor Antagonist Customer List
Table 64. Global Androgen Receptor Antagonist Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Androgen Receptor Antagonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Androgen Receptor Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Androgen Receptor Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Androgen Receptor Antagonist Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Androgen Receptor Antagonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Androgen Receptor Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Androgen Receptor Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Androgen Receptor Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Androgen Receptor Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Androgen Receptor Antagonist Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Androgen Receptor Antagonist Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Androgen Receptor Antagonist Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Androgen Receptor Antagonist Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck & Co., Inc Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck & Co., Inc Androgen Receptor Antagonist Product Portfolios and Specifications
Table 80. Merck & Co., Inc Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck & Co., Inc Main Business
Table 82. Merck & Co., Inc Latest Developments
Table 83. Sanofi Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Androgen Receptor Antagonist Product Portfolios and Specifications
Table 85. Sanofi Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Astellas Pharma Inc Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 89. Astellas Pharma Inc Androgen Receptor Antagonist Product Portfolios and Specifications
Table 90. Astellas Pharma Inc Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Astellas Pharma Inc Main Business
Table 92. Astellas Pharma Inc Latest Developments
Table 93. Pfizer Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Androgen Receptor Antagonist Product Portfolios and Specifications
Table 95. Pfizer Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Johnson & Johnson Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson & Johnson Androgen Receptor Antagonist Product Portfolios and Specifications
Table 100. Johnson & Johnson Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Johnson & Johnson Main Business
Table 102. Johnson & Johnson Latest Developments
Table 103. Bayer Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Androgen Receptor Antagonist Product Portfolios and Specifications
Table 105. Bayer Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Hinova Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 109. Hinova Androgen Receptor Antagonist Product Portfolios and Specifications
Table 110. Hinova Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Hinova Main Business
Table 112. Hinova Latest Developments
Table 113. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product Portfolios and Specifications
Table 115. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Jiangsu Hengrui Pharmaceuticals Co., Ltd Main Business
Table 117. Jiangsu Hengrui Pharmaceuticals Co., Ltd Latest Developments
Table 118. Kintor Pharma Basic Information, Androgen Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 119. Kintor Pharma Androgen Receptor Antagonist Product Portfolios and Specifications
Table 120. Kintor Pharma Androgen Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Kintor Pharma Main Business
Table 122. Kintor Pharma Latest Developments
List of Figures
Figure 1. Picture of Androgen Receptor Antagonist
Figure 2. Androgen Receptor Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Androgen Receptor Antagonist Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Androgen Receptor Antagonist Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Androgen Receptor Antagonist Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of First Generation Inhibitors
Figure 10. Product Picture of Second Generation Inhibitors
Figure 11. Global Androgen Receptor Antagonist Sales Market Share by Type in 2022
Figure 12. Global Androgen Receptor Antagonist Revenue Market Share by Type (2018-2023)
Figure 13. Androgen Receptor Antagonist Consumed in Prostate Cancer
Figure 14. Global Androgen Receptor Antagonist Market: Prostate Cancer (2018-2023) & (K Units)
Figure 15. Androgen Receptor Antagonist Consumed in Breast Cancer
Figure 16. Global Androgen Receptor Antagonist Market: Breast Cancer (2018-2023) & (K Units)
Figure 17. Androgen Receptor Antagonist Consumed in Other
Figure 18. Global Androgen Receptor Antagonist Market: Other (2018-2023) & (K Units)
Figure 19. Global Androgen Receptor Antagonist Sales Market Share by Application (2022)
Figure 20. Global Androgen Receptor Antagonist Revenue Market Share by Application in 2022
Figure 21. Androgen Receptor Antagonist Sales Market by Company in 2022 (K Units)
Figure 22. Global Androgen Receptor Antagonist Sales Market Share by Company in 2022
Figure 23. Androgen Receptor Antagonist Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Androgen Receptor Antagonist Revenue Market Share by Company in 2022
Figure 25. Global Androgen Receptor Antagonist Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Androgen Receptor Antagonist Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Androgen Receptor Antagonist Sales 2018-2023 (K Units)
Figure 28. Americas Androgen Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 29. APAC Androgen Receptor Antagonist Sales 2018-2023 (K Units)
Figure 30. APAC Androgen Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 31. Europe Androgen Receptor Antagonist Sales 2018-2023 (K Units)
Figure 32. Europe Androgen Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Androgen Receptor Antagonist Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Androgen Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 35. Americas Androgen Receptor Antagonist Sales Market Share by Country in 2022
Figure 36. Americas Androgen Receptor Antagonist Revenue Market Share by Country in 2022
Figure 37. Americas Androgen Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 38. Americas Androgen Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 39. United States Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Androgen Receptor Antagonist Sales Market Share by Region in 2022
Figure 44. APAC Androgen Receptor Antagonist Revenue Market Share by Regions in 2022
Figure 45. APAC Androgen Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 46. APAC Androgen Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 47. China Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Androgen Receptor Antagonist Sales Market Share by Country in 2022
Figure 55. Europe Androgen Receptor Antagonist Revenue Market Share by Country in 2022
Figure 56. Europe Androgen Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 57. Europe Androgen Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 58. Germany Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Androgen Receptor Antagonist Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Androgen Receptor Antagonist Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Androgen Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Androgen Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 67. Egypt Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Androgen Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Androgen Receptor Antagonist in 2022
Figure 73. Manufacturing Process Analysis of Androgen Receptor Antagonist
Figure 74. Industry Chain Structure of Androgen Receptor Antagonist
Figure 75. Channels of Distribution
Figure 76. Global Androgen Receptor Antagonist Sales Market Forecast by Region (2024-2029)
Figure 77. Global Androgen Receptor Antagonist Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Androgen Receptor Antagonist Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Androgen Receptor Antagonist Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Androgen Receptor Antagonist Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Androgen Receptor Antagonist Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアンドロゲン受容体拮抗薬市場予測 2023年-2029年] (コード：LP23DC08451)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアンドロゲン受容体拮抗薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のかゆみ止め軟膏市場予測 2023年-2029年
  • 世界の切迫性尿失禁用治療薬市場予測 2023年-2029年
  • 世界の抗アレルギー薬市場予測 2023年-2029年
  • 世界のアダパレンゲル市場予測 2023年-2029年
  • 世界の自閉症スペクトラム障害用治療薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆